Related Experiment Video
Updated: Feb 27, 2026
05:30
Laparoscopic Radical Gastrectomy for Remnant Gastric Cancer
Published on: October 31, 2025
279
Global geriatric oncology: Achievements and challenges
Enrique Soto-Perez-de-Celis1, Nienke A de Glas2, Tina Hsu3
1Department of Medical Oncology and Therapeutics Research, City of Hope, Duarte, CA, USA; Cancer Care in the Elderly Clinic, Department of Geriatrics, Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Mexico City, Mexico.
Journal of Geriatric Oncology
|June 24, 2017
Summary
The global population is aging, increasing cancer cases in older adults. Geriatric oncology initiatives are growing but unequally distributed worldwide, necessitating international collaboration for better cancer care.
Area of Science:
- Geriatric Oncology
- Global Health
- Cancer Care for Older Adults
Background:
- The global population is aging, leading to a rise in age-related noncommunicable diseases, particularly cancer.
- Older adults constitute about half of all cancer cases globally, a proportion expected to increase.
- Many older adults reside in less developed regions with health systems ill-equipped for complex chronic conditions, and a global shortage of geriatric training exists.
Purpose of the Study:
- To provide an overview of geriatric oncology initiatives across different global regions.
- To highlight achievements and challenges in geriatric oncology worldwide.
- To emphasize the importance of international collaboration in geriatric oncology research and training.
Main Methods:
- Review of geriatric oncology initiatives in Asia, Europe, Australia and New Zealand, Latin America, and the United States and Canada.
- Analysis of the availability and distribution of clinical, educational, and research programs in geriatric oncology.
- Synthesis of global efforts to improve care for older adults with cancer.
Main Results:
- Geriatric oncology developments are concentrated in high-income countries, creating significant regional inequalities.
- Various initiatives exist to enhance clinical care, professional training, and research in geriatric oncology.
- There is a global paucity of geriatric training, impacting the oncology workforce's ability to care for older patients.
Conclusions:
- International collaboration in geriatric oncology research and training is crucial for improving care for older adults with cancer.
- Addressing regional inequalities in geriatric oncology services is essential for equitable cancer care.
- Enhanced geriatric skills and knowledge are vital for the oncology workforce to provide comprehensive care to aging populations.
Related Concept Videos
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
284
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
284
01:15Drug Dosing: Geriatric Patients
327
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
327
01:22Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
765
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
765
02:56Treatment Resistant Cancers
3.8K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
01:00Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
299
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
299
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
273
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
273